ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,854 | -19.2% | 19,480 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $145,787 | +73.6% | 18,787 | +19.7% | 0.00% | – |
| Q1 2022 | $84,000 | -66.0% | 15,697 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $247,000 | -31.8% | 16,802 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $362,000 | +24.0% | 17,305 | +4.7% | 0.00% | +100.0% |
| Q2 2021 | $292,000 | -9.9% | 16,534 | +25.2% | 0.00% | 0.0% |
| Q1 2021 | $324,000 | -25.9% | 13,207 | +2.4% | 0.00% | -50.0% |
| Q4 2020 | $437,000 | +236.2% | 12,898 | +147.7% | 0.00% | +100.0% |
| Q3 2020 | $130,000 | -27.8% | 5,207 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $180,000 | – | 5,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,007,576 | $25,199,000 | 12.12% |
| Svennilson Peter | 4,768,181 | $119,252,000 | 9.73% |
| EcoR1 Capital, LLC | 2,642,218 | $66,082,000 | 4.71% |
| Orbimed Advisors | 2,921,967 | $73,078,000 | 0.92% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 312,483 | $7,815,000 | 0.35% |
| EMERALD ADVISERS, LLC | 324,582 | $8,118,000 | 0.33% |
| Casdin Capital, LLC | 251,515 | $6,290,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 995,382 | $24,895,000 | 0.24% |
| Artal Group S.A. | 142,500 | $3,564,000 | 0.09% |
| Alyeska Investment Group, L.P. | 161,585 | $4,041,000 | 0.06% |